Adele Bonato
Verona, 37134, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precision.
Journal: Expert review of clinical pharmacology
Published: May 04, 2026
Microbiome and EGFR-mutant non-small cell lung cancer: a complex interplay.
Journal: Expert review of clinical immunology
Published: March 13, 2026
Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity.
Journal: International journal of molecular sciences
Published: January 28, 2026
Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief Report.
Journal: JTO clinical and research reports
Published: June 06, 2025
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers.
Journal: Oncoimmunology
Published: April 07, 2025
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications.
Journal: Expert review of clinical immunology
Published: June 24, 2024
First-Line Treatments and Management of Metastatic Renal Cell Carcinoma Patients: An Italian Interdisciplinary Uro-Oncologic Group Algorithm.
Journal: Cells
Published: April 29, 2024
Front-Line Therapeutic Strategy in Metastatic Hormone Sensitive Prostate Cancer: An Updated Therapeutic Algorithm.
Journal: Clinical genitourinary cancer
Published: February 27, 2024
Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: February 10, 2024
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival.
Journal: Cancer diagnosis & prognosis
Published: June 12, 2023
Last Updated: 09/26/2026